The Suggestive Gene

Langreth, Robert
September 2006
Forbes Asia;9/4/2006, Vol. 2 Issue 14, p118
The article focuses on the decision of Celera to venture into the diagnostic testing segment. The company tried to sell data from its gene storehouse and then create a production line of wonder drugs to treat cancer and autoimmune disorders but the venture failed to make profits. The company is planning to introduce a test in 2007 called the coronary heart disease genetic risk score.


Related Articles

  • More evidence that earlobe creases mean trouble for CAD patients.  // Modern Medicine;Jul96, Vol. 64 Issue 7, p50 

    Presents an abstract on the article `Diagonal Earlobe Creases and Prognosis in Patients With Suspected Coronary Artery Disease,' by W.J. Elliott and L.H. Powell published in the February 1996 issue of the `American Journal of Medicine'.

  • Neglecting women's hearts.  // Consumer Reports on Health;May94, Vol. 6 Issue 5, p54 

    Reports on the study about the frequency of diagnostic tests and therapeutic interventions for coronary heart disease among women. Comparison with attitudes of men on tests; Relevance of gender on the diagnosis and treatment of coronary disease.

  • TIA: How to know which patients will have major vascular events.  // Geriatrics;Aug93, Vol. 48 Issue 8, p67 

    Reports on a study indicating the characteristics which predict the occurrence of a major vascular event in a patient who has had a transient ischemic attack (TIA) or minor stroke. Presence of diabetes; Computerized tomography evidence of a border zone infarct; Independent risk factors.

  • Here's more evidence that earlobe creases spell trouble in CAD patients. Leibovitch, Eric R. // Geriatrics;Aug96, Vol. 51 Issue 8, p65 

    Discusses the study `Diagonal earlobe creases and prognosis in patients with suspected coronary artery disease,' by W.J. Elliott and L.H. Powell.

  • Diagnosing CAD.  // Geriatrics;Jan98, Vol. 53 Issue 1, p25 

    Focuses on the utilization of an arbutamine HCl injection (GenESA) system to diagnose coronary artery disease (CAD). Details on the system; Statistical findings of clinical trials using the system.

  • What erodes the female CHD advantage. Pinkowish, Mary Desmond // Patient Care;3/15/1995, Vol. 29 Issue 5, p110 

    Presents the reprint of `Risk factors that attenuate the female coronary disease advantage,' by WB Kannel, PWF Wilson in `Arch Intern Med 1995.'

  • CAD: It's not only what you eat, but what eats you.  // Modern Medicine;Jan95, Vol. 63 Issue 1, p42 

    Presents an abstract of the article `Hostility in Asymptomatic Men With Angiographically Confirmed Coronary Artery Disease,' by J.C. Barefoot, J.C. Patterson et al from the American Journal of Cardiology dated September, 1994.

  • Measure troponin T when assessing risk in patients with unstable CAD.  // Modern Medicine;Aug96, Vol. 64 Issue 8, p51 

    Presents an abstract of a research titled `Relation Between Troponin T and the Risk of Subsequent Cardiac Events in Unstable Coronary Artery Disease,' by B. Lindahl, P. Venge, L. Wallentin et al, published in the May 1, 1996 issue of `Circulation.'

  • The Diagnosis of Coronary Heart Disease in a Low-Prevalence Setting. Bösner, Stefan; Haasenritter, Jörg; Keller, Heidi; Hani, Maren Abu; Sönnichsen, Andreas C.; Baum, Erika; Donner-Banzhoff, Norbert // Deutsches Aerzteblatt International;7/1/2011, Vol. 108 Issue 26, following p451 

    References for the article "The Diagnosis of Coronary Heart Disease in a Low-Prevalence Setting," published in the July 1, 2011 issue of "Deutsches Urnal," are presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics